Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection - Wikidata - wikimedia - TriplyDB

Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection

Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection

http://www.wikidata.org/entity/Q34506677

about

Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive Review Bone health in HIV and hepatitis B or C infections Lifetime and recent alcohol use and bone mineral density in adults with HIV infection and substance dependence Tenofovir: What We Have Learnt After 7.5 Million Person-Years of Use.Mechanism of enhanced antiosteoporosis effect of circinal-icaritin by self-assembled nanomicelles in vivo with suet oil and sodium deoxycholate B Cell Production of Both OPG and RANKL is Significantly Increased in Aged Mice Loss of marginal zone B-cells in SHIVSF162P4 challenged rhesus macaques despite control of viremia to low or undetectable levels in chronic infection.Role of T-cell reconstitution in HIV-1 antiretroviral therapy-induced bone loss.Bone loss in HIV: a contemporary review.Osteoporotic bone of miR-150-deficient mice: Possibly due to low serum OPG-mediated osteoclast activation.Complete manuscript Title: Changes in RANKL during the first two years after cART initiation in HIV-infected cART naïve adults.Antiretroviral therapy induces a rapid increase in bone resorption that is positively associated with the magnitude of immune reconstitution in HIV infection Immunology of Osteoporosis: A Mini-Review.Vitamin D and bone loss in HIV Does systemic inflammation and immune activation contribute to fracture risk in HIV?Bone health in persons with haemophilia.Bone Loss in HIV Infection.Physiological and pathophysiological bone turnover - role of the immune system.Bone Loss Among Women Living With HIV.Parathyroid Diseases and T Cells.Bone mineral density in people living with HIV: a narrative review of the literature.Improvement of BMD after Switching from Lopinavir/R Plus Two Nucleos(T)ide Reverse Transcriptase Inhibitors to Lopinavir/R Plus Lamivudine: OLE-LIP Substudy.Abnormal Bone Acquisition With Early-Life HIV Infection: Role of Immune Activation and Senescent Osteogenic Precursors.Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021 HIV Infection and Bone Abnormalities.Homeostatic Expansion of CD4+ T-cells Promotes Cortical and Trabecular Bone Loss while CD8+ T-cells Induce Trabecular Bone Loss Only.Beyond Antibodies: B Cells and the OPG/RANK-RANKL Pathway in Health, Non-HIV Disease and HIV-Induced Bone Loss.Bone and the Immune System.Bone degradation machinery of osteoclasts: An HIV-1 target that contributes to bone loss.T-cell receptor activator of nuclear factor-κB ligand/osteoprotegerin imbalance is associated with HIV-induced bone loss in patients with higher CD4+ T-cell counts.Neutralization of CD40 ligand costimulation promotes bone formation and accretion of vertebral bone mass in mice.CTLA-4Ig (abatacept) balances bone anabolic effects of T cells and Wnt-10b with antianabolic effects of osteoblastic sclerostin.Deciphering how HIV-1 weakens and cracks the bone.Prevention and Treatment of Osteoporosis Using Chinese Medicinal Plants: Special Emphasis on Mechanisms of Immune Modulation.

P2860

Q26774874-B3D93353-F5D7-49F0-912E-EB3C6E63982D Q30238946-379A4A35-E692-4199-93ED-3CECF3A5C390 Q33627227-11ACE415-5551-40C3-B266-C9357BBCAC93 Q34478840-BBDACBCA-73B7-41BD-8471-019C6A24B51B Q35238561-48922261-3071-45DE-9DAC-C1B29C3B2F96 Q35598428-A36DBE26-0F23-41A7-92E5-0027E954CD5E Q36052919-A2ECD9C2-AB66-455D-8248-3CB8181F15CF Q36087907-C43AA21F-7700-4EFF-8032-DA41032893D7 Q36330955-699A1C53-36E2-4E63-8585-DD4B5947D860 Q36335245-F9C8E9D8-50C5-48D0-907B-398B3E283B9C Q36343699-7D0A39D5-F869-44BA-95DD-A1899ED66D48 Q36462148-C8E924AB-6FFC-4C53-965A-B8CBCBEA79C8 Q36766801-C15656F8-1AB6-472D-B05E-45BEE35399C8 Q36816930-78005450-8544-42DA-A272-E63441A8420D Q37138907-78B7EE4F-22A0-4A6B-934C-4519BF9FDB6B Q38546824-44974261-7860-459D-B078-3FFCBAE813D6 Q38835028-00771568-5FA9-45C3-B9F2-DC0DFA88E893 Q38867785-CB42D3A0-80E1-4053-8812-C1222C27A580 Q38966358-E86196B2-C7E7-4B0C-94A2-AE596AD47FC4 Q39249931-4659E515-0E18-4E28-B6F1-D05B180D0320 Q40107245-5EA34D56-0B54-40D8-AA7A-6F0E5B0EDC7B Q40695106-C148E53C-DE34-4B93-8F18-192CE8834BD3 Q40708846-C36CD462-6DC2-4814-BE57-2E293680ECC2 Q40788143-376BD039-0D7B-4E64-A73B-415C95F78330 Q41877618-1BFD4243-78E0-4F43-AF3F-4118B51379AB Q41992224-E666B7D6-F3BF-427B-8E56-996E16E7AC56 Q47194100-7733D847-8E68-4118-83D1-2927F2B2C2B0 Q47608253-2D7F3B3A-9036-4726-B7F6-6FB196292D1C Q49790704-6683FAB3-8BDF-4D06-9190-2B5C101E022D Q50051644-D761D216-DC2E-4CB6-A4ED-7AFB88DF16A8 Q52664597-2FCFCB4C-DC36-4029-B5F6-9063A5B3CD09 Q52729141-387326B2-93A4-4413-B0C4-DB35C017AA68 Q54263701-043C304D-7812-40C9-874C-E3BADABDC06D Q55410884-C1F82DC5-4443-4612-8933-19DA8703048B

P2860

Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection

http://www.wikidata.org/entity/Q34506677

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Dysregulated B cell expression ...... neral density in HIV infection

@ast

Dysregulated B cell expression ...... neral density in HIV infection

@en

Dysregulated B cell expression ...... neral density in HIV infection

@nl

type

label

Dysregulated B cell expression ...... neral density in HIV infection

@ast

Dysregulated B cell expression ...... neral density in HIV infection

@en

Dysregulated B cell expression ...... neral density in HIV infection

@nl

prefLabel

Dysregulated B cell expression ...... neral density in HIV infection

@ast

Dysregulated B cell expression ...... neral density in HIV infection

@en

Dysregulated B cell expression ...... neral density in HIV infection

@nl

P1433

Q34506677-06DF6581-CF57-42CE-9192-F30B75B6A5CF

P1476

Q34506677-8DE7D55C-3B1F-475C-8DE6-FA54021B08EE

P2093

Q34506677-13ED982D-17EC-406B-A244-54EB885AA488

Q34506677-17AE65F5-D362-4347-969C-808E321D4F83

Q34506677-58598763-4445-4DD1-93A9-6F29CB5B85BB

Q34506677-7846BBE2-4DB7-4D59-8980-61B0AE67B5D1

Q34506677-BBABBB41-4160-4DCB-AC6F-DAE49F835685

Q34506677-C6065597-77B2-47BE-AC40-9DA0D461A9FB

Q34506677-C6EA47BE-DD93-4E56-925E-3CA3F1E8D626

Q34506677-C9E5B6FC-777F-48E4-9023-68791FD6FAA6

Q34506677-D482B304-E8B0-4577-8CAC-C73060DCD24C

Q34506677-EFFEBF58-0D84-4580-B79E-5F23A708F546

P2860

Q34506677-1185B79F-605A-4C47-AFB0-7983BA25CD24

Q34506677-16E641CF-B46A-484B-AF48-1341E5053420

Q34506677-196DF63A-306A-4807-BDF7-37FEBA5540CC

Q34506677-42CB5FB8-E17D-4AA4-A6C2-1F9318CD2334

Q34506677-44918190-19EF-494E-925F-3537213C53A2

Q34506677-4AFBE70C-811B-4C1F-800F-9114759A8E20

Q34506677-4E6B5159-9786-4EB2-AD00-6D80A78A1A80

Q34506677-51BAAE51-42C7-4E6B-99B3-5B38B8D8C072

Q34506677-685A111A-C908-43C1-887D-EE3ABF56D0D2

Q34506677-71E21E57-DC19-4836-8973-93B583846E2B

P304

Q34506677-CD6CB2A6-BCAF-4932-B3D2-0F073866B85B

P31

Q34506677-E5409F24-AD71-4A38-A494-AA6B225EB931

P356

Q34506677-BC50ECEE-3DAF-4EA1-AA1E-0E3967E3BC5A

P433

Q34506677-224AB0EC-EEF6-4A84-804F-5985A81D1D4A

P478

Q34506677-14F2960D-4BC1-4856-907F-BF7641C619EA

P50

Q34506677-01E9B11E-9284-43BE-97DD-1EFF860D4ACD

P577

Q34506677-098F6A9C-46A9-45CF-93AD-410BA7679DC7

P5875

Q34506677-D4CD43B6-D2F4-4608-BEF3-60618451B8FF

P698

Q34506677-15E910C9-139A-4882-AB81-B0D665912179

P932

Q34506677-6892E36E-EFA7-4F05-A9A1-92FB43AFDEEC

P356

JOURNAL.PPAT.1004497

P1433

P1476

Dysregulated B cell expression ...... neral density in HIV infection

@en

P2093

Anandi N Sheth

http://www.w3.org/2001/XMLSchema#string

Andrea Knezevic

http://www.w3.org/2001/XMLSchema#string

Antonina Foster

http://www.w3.org/2001/XMLSchema#string

Aswani Vunnava

http://www.w3.org/2001/XMLSchema#string

Cecile Delille

http://www.w3.org/2001/XMLSchema#string

Ighovwerha Ofotokun

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Lennox

http://www.w3.org/2001/XMLSchema#string

Kehmia Titanji

http://www.w3.org/2001/XMLSchema#string

M Neale Weitzmann

http://www.w3.org/2001/XMLSchema#string

Sara E Sanford

http://www.w3.org/2001/XMLSchema#string

P2860

Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review

Bone resorption by osteoclasts

IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults.

Increased risk of fragility fractures among HIV infected compared to uninfected male veterans.

Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats.

Minireview: the OPG/RANKL/RANK system.

Estrogen deficiency and bone loss: an inflammatory tale.

B cells in HIV infection and disease

P304

e1004497

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1004497

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268234103

http://www.w3.org/2001/XMLSchema#string

P698

25393853

http://www.w3.org/2001/XMLSchema#string

P932

4231117

http://www.w3.org/2001/XMLSchema#string